miRagen Therapeutics' Series A - II Round

miRagen Therapeutics raised a round of funding on June 16, 2009.

miRagen Therapeutics (NASDAQ: MGEN) is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative microRNA (miRNA)-targeting therapies in disease areas of high u…

Articles about miRagen Therapeutics' Series A - II Round: